Q2 Special – 

Buy any proprietary ionizable lipids, get a FREE EPO mRNA

Buy any proprietary ionizable lipids, get a free EPO mRNA

EPO (erythropoietin)-mRNA encodes erythropoietin, a hormone that stimulates red blood cell (RBC) production, and is typically encapsulated by lipid nanoparticles (LNPs). Ionizable lipids are essential components in LNP formulations, the most advanced platform for RNA delivery. LNPs protect the mRNA from degradation and facilitate its entry into cells. Once inside the cell, the mRNA is translated into EPO, stimulating the body’s own natural red blood cell production.

EPO mRNA is often used as a surrogate when investigating LNP formulation in mouse models because it provides a readily measurable endpoint.

For a limited time until June 30 2025, purchase any of the following 3 products:

  • Cat. No: LNP007-1 | Ionizable Lipid 007, 1g (Price: $2,000)
  • Cat. No: LNP009-1 | Ionizable Lipid 009, 1g (Price: $2,000)
  • Cat. No: LNP016-1 | Ionizable Lipid 016, 1g (Price: $2,000)

Get a FREE:

  • Cat. No: 11021-5CAP-1 | EPO mRNA with N1-Me-pUTP (5’CAP 5011), 1mg
    (Value at: $1,000)

To redeem the promo offer, use code: $LNPDEAL 

About Ionizable Lipids
Areterna’s proprietary Ionizable lipids for LNP formulation offers higher payload delivery efficiency compared to benchmark lipids across various tested applications, including gene therapy, protein replacement, and vaccine development. 

In vaccine studies, LNP007 and LNP009 induces 4–6 times higher IgG titers in mice and non-human primates (NHPs) compared to SM-102. In gene editing studies, LNP016 is found to outperform LP01 in mice. 

  • Ionizable Lipid 007 for prophylactic and cancer immunotherapies
  • Ionizable Lipid 009 for prophylactic and cancer immunotherapies
  • Ionizable Lipid 016 for gene editing or protein replacement
More about LNP Products

About EPO mRNA
EPO-mRNA with N1-Me-pUTP capped with CAP5011 produces mRNA with a Cap1 structure. The innovation of Areterna’s novel cap analog, CAP5011, comes from the vinylphosphonic acid modification (ENE) of linkage between the m7G cap and 1st ribonucleic acid. CAP5011 offers better protein expression than other generations of cap analogs.

More about Tool mRNAs

How to order

Simply contact your Areterna sales rep or email sales@areterna.com and mention the promo code $LNPDEAL

Terms and Conditions: Promotion valid for all customers in the US and EU only from April 1, 2025, to June 30, 2025. The buyer is responsible for shipping and handling costs. Products are not eligible for return. Discounts cannot be combined with other offers, promotions, or discounts. Promotion voids where prohibited, licensed, or restricted by federal, state, provincial, or local laws or regulations or agency/institutional policy. Areterna may modify or cancel this promotion at any time without notice.